Photo of Olle Stål

Olle Stål




Christine Lundgren, Julia Tutzauer, Sarah E. Church, Olle Stål, Maria Ekholm, Carina Forsare, Bo Nordenskjöld, Marten Ferno, Par-Ola Bendahl, Lisa Ryden (2023) Tamoxifen-predictive value of gene expression signatures in premenopausal breast cancer: data from the randomized SBII:2 trial Breast Cancer Research, Vol. 25, Article 110 Continue to DOI
Anna Nordenskjold, Helena Fohlin, Johan Rosell, Nils-Olof Bengtsson, Tommy Fornander, Thomas Hatschek, Henrik Lindman, Per Malmstrom, Lisa Ryden, Arne Wallgren, Olle Stål, Bo Nordenskjöld (2023) Breast cancer survival and incidence of second primary cancers after 30 years in a randomized study of two versus five years of adjuvant tamoxifen therapy Breast, Vol. 71, p. 63-68 Continue to DOI


Annelie Johansson, Huma Dar, Laura J. van t Veer, Nicholas P. Tobin, Gizeh Perez-Tenorio, Anna Nordenskjöld, Ulla Johansson, Johan Hartman, Lambert Skoog, Christina Yau, Christopher C. Benz, Laura J. Esserman, Olle Stål, Bo Nordenskjöld, Tommy Fornander, Linda S. Lindstrom (2022) Twenty-Year Benefit From Adjuvant Goserelin and Tamoxifen in Premenopausal Patients With Breast Cancer in a Controlled Randomized Clinical Trial Journal of Clinical Oncology, Vol. 40, p. 4071-4082 Continue to DOI